Marimed (MRMD) Capital Leases (2019 - 2026)

Marimed (MRMD) has reported Capital Leases for 8 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Leases fell 35.8% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $1.4 million, a 35.8% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, up 1.56% from the prior year.
• Capital Leases was $1.4 million for Q2 2026 at Marimed, down from $1.6 million in the prior quarter.
• Over five years, Capital Leases peaked at $2.7 million in Q2 2024 and troughed at $338000.0 in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2023 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases jumped 1995.45% in 2022 and sank 35.8% in 2026, its largest moves.
• Over 5 years, Capital Leases stood at $461000.0 in 2022, then surged by 364.21% to $2.1 million in 2023, then slipped by 10.0% to $1.9 million in 2024, then increased by 1.56% to $2.0 million in 2025, then fell by 27.4% to $1.4 million in 2026.
• The last three Capital Leases figures came in at $1.4 million (Q2 2026), $1.6 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.